$RSI
Rush Street Interactive Inc

2020 Q1 Form 10-Q Financial Statement

#000119312520136217 Filed on May 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$170.6K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $349.8K
YoY Change
Income Tax $98.69K
% Of Pretax Income 28.21%
Net Earnings $251.1K
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.463M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $330.4K
Receivables
Other Receivables
Total Short-Term Assets $1.793M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $230.5M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.793M
Total Long-Term Assets $230.5M
Total Assets $232.3M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $384.4K
YoY Change
Accrued Expenses $50.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $583.6K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $583.6K
Total Long-Term Liabilities
Total Liabilities $8.634M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $250.4K
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.000M
YoY Change
Total Liabilities & Shareholders Equity $232.3M
YoY Change

Cashflow Statement

Concept 2020 Q1
OPERATING ACTIVITIES
Net Income $251.1K
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$66.71K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$230.0M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 231.5M
YoY Change
NET CHANGE
Cash From Operating Activities -66.71K
Cash From Investing Activities -230.0M
Cash From Financing Activities 231.5M
Net Change In Cash 1.463M
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$66.71K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dmyt Net Income Loss Attributable To Common Class B
NetIncomeLossAttributableToCommonClassB
-120000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
232313714
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.00
CY2020Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
8050000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
5000006
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
21868007 shares
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
583638
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
384448
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1462947
CY2020Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
330358
CY2020Q1 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2020Q1 us-gaap Assets Current
AssetsCurrent
1793305
CY2020Q1 us-gaap Assets
Assets
232313714
CY2020Q1 us-gaap Cash
Cash
1462947
CY2020Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2020Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
50500
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1462947
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
218680070
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
250424
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4748894
CY2020Q1 us-gaap Liabilities
Liabilities
8633638
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
50000
CY2020Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
230520409
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
98690
CY2020Q1 dmyt Deferred Underwriter Fee
DeferredUnderwriterFee
8050000
CY2020Q1 dmyt Working Capital
WorkingCapital
1200000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
24280
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2019Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24425
CY2019Q4 us-gaap Liabilities
Liabilities
49076
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
73356
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
49076
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
33440
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15636
CY2019Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
73356
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-720
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Assets
Assets
73356
CY2020Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
23000000 shares
CY2020Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
230000000
CY2020Q1 dmyt Initial Public Offering Costs
InitialPublicOfferingCosts
13200000
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
230000000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
251144
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
383728
CY2020Q1 us-gaap Taxes Other
TaxesOther
149000
CY2020Q1 us-gaap Franchisor Costs
FranchisorCosts
50500
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
120120
CY2020Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
24990
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
DMY TECHNOLOGY GROUP, INC.
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001793659
CY2020Q1 dei Entity File Number
EntityFileNumber
001-39232
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-3626708
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1180 North Town Center Drive
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2020Q1 dei City Area Code
CityAreaCode
702
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
781-4313
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Shell Company
EntityShellCompany
true
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89144
CY2020Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
330358
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
98690
CY2020Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> <b><i>Concentration of Credit Risk</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. At March&#xA0;31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p> </div>
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
98690
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
251144
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
6600000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
13195348
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1462947
CY2020Q1 us-gaap Common Stock Voting Rights
CommonStockVotingRights
Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of our stockholders except as required by law.
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-230000000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
231529652
CY2020Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
90000 shares
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of the financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Making estimates requires management to exercise significant judgment.&#xA0;It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future conforming events.&#xA0;Accordingly, the actual results could differ from those estimates.</p> </div>
CY2020Q1 us-gaap Interest Income Operating
InterestIncomeOperating
520000
CY2020Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
25000
CY2020Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6600000
CY2020Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
230000000
CY2020Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
5005494
CY2020Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
89844
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-66705
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2020Q1 us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
4600000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
349834
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-170620
CY2020Q1 dmyt Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
50000
CY2020Q1 dmyt Warrants Expiration Term Description
WarrantsExpirationTermDescription
Five years after the completion of a Business Combination or earlier upon redemption or liquidation
CY2020Q1 dmyt Warrants Expire Date
WarrantsExpireDate
Upon a minimum of 30 days' prior written notice of redemption
CY2020Q1 dmyt Warrant Redemption Price Description
WarrantRedemptionPriceDescription
At a price of $0.01 per warrant
CY2020Q1 dmyt Class Of Warrant Or Right Exercisable Description
ClassOfWarrantOrRightExercisableDescription
On the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering
CY2020Q1 dmyt Noncash Deferred Underwriting Commissions
NoncashDeferredUnderwritingCommissions
8050000
CY2020Q1 dmyt Shares Subject To Possible Redemption Amount
SharesSubjectToPossibleRedemptionAmount
218680070
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dmyt Underwriting Discount Of Per Unit
UnderwritingDiscountOfPerUnit
0.20
CY2020Q1 dmyt Additional Fee For Deferred Underwriting Commissions Per Unit
AdditionalFeeForDeferredUnderwritingCommissionsPerUnit
0.35
CY2020Q1 dmyt Gain On Marketable Securities Net Dividends And Interest Held In Trust Account
GainOnMarketableSecuritiesNetDividendsAndInterestHeldInTrustAccount
520454
CY2020Q1 dmyt Net Income Loss Attributable To Common Class A
NetIncomeLossAttributableToCommonClassA
371000
CY2020Q1 dmyt Cash Deposited In Trust Account
CashDepositedInTrustAccount
230000000
CY2020Q1 dmyt Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
50500
CY2020Q1 dmyt Offering Costs Included In Note Payable
OfferingCostsIncludedInNotePayable
64854
CY2020Q1 dmyt Business Combination Required Completion Period After Initial Public Offering
BusinessCombinationRequiredCompletionPeriodAfterInitialPublicOffering
P24M
CY2020Q1 dmyt Business Combination Required Completion Date After Initial Public Offering
BusinessCombinationRequiredCompletionDateAfterInitialPublicOffering
2022-02-25
CY2020Q1 dmyt Noncash Gain On Marketable Securities Net Dividends And Interest Held In Trust Account
NoncashGainOnMarketableSecuritiesNetDividendsAndInterestHeldInTrustAccount
520409
CY2020Q1 dmyt Business Combination Within In Combination Period Possible Per Share Value Of Residual Assets Remaining Available For Distribution
BusinessCombinationWithinInCombinationPeriodPossiblePerShareValueOfResidualAssetsRemainingAvailableForDistribution
10.00

Files In Submission

Name View Source Status
0001193125-20-136217-index-headers.html Edgar Link pending
0001193125-20-136217-index.html Edgar Link pending
0001193125-20-136217.txt Edgar Link pending
0001193125-20-136217-xbrl.zip Edgar Link pending
d923480d10q.htm Edgar Link pending
d923480dex311.htm Edgar Link pending
d923480dex312.htm Edgar Link pending
d923480dex321.htm Edgar Link pending
d923480dex322.htm Edgar Link pending
dmyt-20200331.xml Edgar Link completed
dmyt-20200331.xsd Edgar Link pending
dmyt-20200331_cal.xml Edgar Link unprocessable
dmyt-20200331_def.xml Edgar Link unprocessable
dmyt-20200331_lab.xml Edgar Link unprocessable
dmyt-20200331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending